Cargando…

Real-world effectiveness of osteoporosis treatments in Germany

SUMMARY: This observational study assessed the impact on the fracture incidence of osteoporosis medications in postmenopausal women in Germany. Continued treatment with osteoporosis medications was associated with reductions of fracture rates in a real-world setting. PURPOSE: The efficacy of osteopo...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Kelly, James, Bartsch, Robert, Kossack, Nils, Borchert, Julia, Pignot, Marc, Hadji, Peyman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512727/ https://www.ncbi.nlm.nih.gov/pubmed/36044096 http://dx.doi.org/10.1007/s11657-022-01156-z

Ejemplares similares

Correction: Real-world effectiveness of osteoporosis treatments in Germany
por: O’Kelly, James, et al.
Publicado: (2022)

Real-world effectiveness of osteoporosis treatment in the oldest old
por: Ström, O., et al.
Publicado: (2020)

Gender- and age-related treatment compliance in patients with osteoporosis in Germany
por: Hadji, Peyman, et al.
Publicado: (2016)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis
por: STÄNDER, Sonja, et al.
Publicado: (2020)

Real‐World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study
por: Bosco‐Lévy, Pauline, et al.
Publicado: (2023)

Prevalence of FRAX risk factors and the osteoporosis treatment gap among women ≥ 70 years of age in routine primary care across 8 countries in Europe
por: McCloskey, Eugene, et al.
Publicado: (2022)

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
por: McCloskey, E., et al.
Publicado: (2020)

Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
por: Fahrleitner-Pammer, A., et al.
Publicado: (2017)

Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Women with Pregnancy- and Lactation-associated Osteoporosis and Vertebral Fractures
por: Hadji, Peyman, et al.
Publicado: (2022)

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
por: Johnson, Ben, et al.
Publicado: (2021)

Real World Experience of Denosumab Treatment in the Belfast Osteoporosis Service
por: Moran, CP, et al.
Publicado: (2019)

Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time
por: Sprenger, Ralf, et al.
Publicado: (2022)

Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort study
por: Pedersen, Alma B., et al.
Publicado: (2023)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

The association between keloid and osteoporosis: real-world evidence
por: Lu, Chun-Ching, et al.
Publicado: (2021)

Comparison between real-world practice and application of the FRAX algorithm in the treatment of osteoporosis
por: Zoccarato, Francesca, et al.
Publicado: (2022)

Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data
por: Hadji, Peyman, et al.
Publicado: (2021)

Romosozumab, clinical trials, and real-world care of patients with osteoporosis
por: Lewiecki, E. Michael
Publicado: (2020)

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
por: Hauser, Barbara, et al.
Publicado: (2021)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

12-month prevalence of osteoporosis in Germany
por: Fuchs, Judith, et al.
Publicado: (2017)

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany
por: Murgas, Sandra, et al.
Publicado: (2019)

Real‐world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany
por: Wachter, Rolf, et al.
Publicado: (2019)

Osteoporosis-related characteristics in care home residents in England: a retrospective cohort study
por: Gerasimaviciute, Vaiva, et al.
Publicado: (2023)

The evolution of selective estrogen receptor modulators in osteoporosis therapy
por: Hadji, P.
Publicado: (2012)

Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
por: Yusuf, Akeem A., et al.
Publicado: (2018)

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis
por: Stein, Jürgen, et al.
Publicado: (2018)

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
por: Grellmann, Claudia, et al.
Publicado: (2020)

The burden of hyperkalemia in Germany – a real world evidence study assessing the treatment and costs of hyperkalemia
por: Haas, Jennifer Scarlet, et al.
Publicado: (2020)

Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data
por: May, Melanie, et al.
Publicado: (2023)

An Evaluation of Treatment Patterns for Osteoporosis and Outcomes After a Fragility Fracture in a Real-World Setting
por: Singer, Andrea J., et al.
Publicado: (2023)

First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study
por: Schwarting, Andreas, et al.
Publicado: (2016)

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)

Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis
por: Fiehn, Christoph, et al.
Publicado: (2023)

Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: An observational study
por: Modi, Ankita, et al.
Publicado: (2016)

The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization
por: Schwarting, Andreas, et al.
Publicado: (2021)

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany
por: Diel, R., et al.
Publicado: (2020)

Evaluation of bone density and hand grip strength in the course of drug treatment for osteoporosis: A real-world study
por: Schröder, Guido, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uh2lkv5402mf1u2ejcqb71bbt1